HISTOGENICS
Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Our regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Our first investigational product candidate, NeoCart®, leverages our platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.
HISTOGENICS
Industry:
Biotechnology Health Care Medical
Founded:
2000-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.histogenics.com
Total Employee:
51+
Status:
Active
Contact:
(781) 547-4452
Total Funding:
209.5 M USD
Technology used in webpage:
Microsoft Exchange Online IPv6 Pound Sterling Microsoft Japanese Yen Microsoft Azure Network Solutions DNS Facebook Like Comcast Akamai Hosted
Similar Organizations
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
LyGenesis
LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Board_member
2012-07-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2011-05-16 | ProChon Biotech | ProChon Biotech acquired by Histogenics | N/A |
Investors List
Sofinnova Investments
Sofinnova Investments investment in Post-IPO Equity - Histogenics
Split Rock Partners
Split Rock Partners investment in Post-IPO Equity - Histogenics
Precigen
Precigen investment in Post-IPO Equity - Histogenics
BioMed Ventures
BioMed Ventures investment in Series C - Histogenics
Split Rock Partners
Split Rock Partners investment in Series C - Histogenics
Sofinnova Investments
Sofinnova Investments investment in Series C - Histogenics
Foundation Medical Partners
Foundation Medical Partners investment in Series B - Histogenics
Boston Millennia Partners
Boston Millennia Partners investment in Series B - Histogenics
Stryker
Stryker investment in Series A - Histogenics
Howmedica
Howmedica investment in Series A - Histogenics
Official Site Inspections
http://www.histogenics.com
- Host name: wf.networksolutions.com
- IP address: 205.178.189.131
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Histogenics"
Histogenics Company Profile - Office Locations, Competitors
Sep 26, 2019 Histogenics is a company focused on developing products that meaningfully improve the lives of patients with defects in cartilage and joints. Its regenerative medicine …See details»
Histogenics Corporation Company Overview, Contact Details
Histogenics Corporation. Biotechnology Research Massachusetts, United States 51-200 Employees. Histogenics was acquired by Ocugen, (Nasdaq: OCGN) on September 27, 2019. …See details»
Histogenics Corporation - LinkedIn
Histogenics (Nasdaq: HSGX) is a leader in personalized restorative cell therapies (RCT) for active living. Our first investigational product candidate, NeoCart® is a proprietary RCT that rebuilds ...See details»
Press Release Distribution and Management - GlobeNewswire
WALTHAM, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset …See details»
Histogenics 2025 Company Profile: Valuation, Investors …
What industry is Histogenics in? Histogenics’s primary industry is Therapeutic Devices. Is Histogenics a private or public company? Histogenics is a Private company. What is Histogenics’s current revenue? The current revenue for …See details»
Histogenics Corp. Company Profile | StatInvestor
Histogenics Corp. engages in the development, marketing, and commercialization of musculoskeletal medicine. Its regenerative medicine platform combines expertise in cell …See details»
Histogenics Headquarters and Office Locations - Craft
Histogenics Headquarters and Office Locations. Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit. Button CTA. Histogenics is headquartered in Waltham, 830 Winter …See details»
Histogenics - Funding, Financials, Valuation & Investors
Histogenics is registered under the ticker NASDAQ:HSGX . Their stock opened with $11.00 in its Dec 3, 2014 IPO. Histogenics is funded by 11 investors. Sofinnova Investments and Split Rock …See details»
Histogenics - Boston Millennia Partners
Dec 3, 2014 Histogenics leverages a combination of the latest advances in molecular biology and proprietary materials sciences to create products designed to help improve patient …See details»
Histogenics Corp. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Histogenics Corp. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 15 news, and 14 literature, Disease Domain:Hemic and Lymphatic Diseases, Immune …See details»
Histogenics - Products, Competitors, Financials, Employees ...
Histogenics' flagship products focus on the treatment of active patients suffering from articular cartilage derived pain and immobility. The Company takes an interdisciplinary …See details»
Histogenics - Company Profile - Tracxn
Feb 24, 2025 Histogenics. has raised a total funding of $116M over 6 rounds. Its first funding round was on Aug 22, 2006. List of recent funding rounds of Histogenics. Date of funding. …See details»
Histogenics - Contacts, Employees, Board Members, Advisors
Histogenics is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair.See details»
Histogenics CEO and Key Executive Team | Craft.co
Histogenics's President and Chief Executive Officer is Adam Gridley. Other executives include E. Lynne Kelley, Chief Medical Officer; Jon Lieber, CFO and 7 others. See the full leadership …See details»
Histogenics CEO, Founder, Key Executive Team, Board of Directors ...
Histogenics has 3 board of directors, including David Gill. Name. Firm. Work History. Other Seats. David Gill. David N. Gill has over 30 years’ experience in senior operating and financial roles …See details»
Histogenics - Golden
Histogenics is a biotechnology company that focuses on the development of restorative cell therapies. Histogenics develops restorative cell therapies that may offer rapid-onset pain relief …See details»
Histogenics Corporation Announces Approval of Merger by
Sep 26, 2019 Forward-looking statements involve risks and uncertainties, and include, but are not limited to, statements about the expected final results of the voting of Histogenics’ …See details»
Ocugen, Histogenics merge to form eye disease specialist
Apr 8, 2019 The stock-for-stock deal provides a short-cut to a stock exchange listing for privately-held Ocugen, and gives Histogenics’ shareholders a stake in a combined company …See details»
Histogenics signs merger agreement with Ocugen
Apr 8, 2019 Gunderson Dettmer client Histogenics, a developer of restorative cell therapies for pain management, has entered into a definitive merger agreement with Ocugen, a privately …See details»
History of Genomics Program - National Human Genome …
4 days ago The History of Genomics Program maintains and provides access to the world’s largest single repository of historically significant materials from the Human Genome Project, …See details»